Castlight Health (CSLT) Earning Somewhat Favorable News Coverage, Accern Reports
News stories about Castlight Health (NYSE:CSLT) have been trending somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Castlight Health earned a news sentiment score of 0.21 on Accern’s scale. Accern also assigned news stories about the software maker an impact score of 45.538183384734 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
A number of research firms recently commented on CSLT. Zacks Investment Research downgraded Castlight Health from a “hold” rating to a “sell” rating in a report on Monday, February 26th. Chardan Capital reiterated a “buy” rating and issued a $5.75 price objective (down previously from $6.30) on shares of Castlight Health in a report on Thursday, February 22nd. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $5.00 price objective on shares of Castlight Health in a report on Wednesday, February 21st. Four analysts have rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $5.04.
Shares of Castlight Health (NYSE:CSLT) opened at $3.70 on Friday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.06 and a current ratio of 2.06. Castlight Health has a fifty-two week low of $3.10 and a fifty-two week high of $4.75.
In other news, CFO Mangini Siobhan Nolan sold 18,201 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $3.63, for a total transaction of $66,069.63. Following the completion of the transaction, the chief financial officer now directly owns 120,788 shares of the company’s stock, valued at $438,460.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO John C. Doyle sold 10,644 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $3.63, for a total value of $38,637.72. Following the transaction, the chief executive officer now directly owns 157,422 shares of the company’s stock, valued at $571,441.86. The disclosure for this sale can be found here. Insiders have sold 33,184 shares of company stock valued at $120,762 over the last ninety days. 37.43% of the stock is owned by insiders.
About Castlight Health
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.